Related by context. All words. (Click for frequent words.) 68 excessive sleepiness 64 hypersomnia 64 ropinirole 64 circadian rhythm sleep 64 diabetic neuropathic pain 63 ramelteon 63 gaboxadol 63 desvenlafaxine succinate 63 tasimelteon 63 Major Depressive Disorder MDD 63 RLS symptoms 62 dyskinesia PD LID 62 chronic insomnia 62 eszopiclone 62 VA# [002] 62 cannabinor 62 IBS C 61 Restless Legs Syndrome RLS 61 Almorexant 61 obstructive sleep apnea hypopnea 61 generalized epilepsy 61 overactive bladder symptoms 61 generalized anxiety disorder GAD 61 eosinophilic asthma 61 insomnia 61 DDP# 61 nausea vomiting headache 61 vasomotor symptoms 61 constipation OIC 61 visilizumab 60 daytime alertness 60 salivary cortisol 60 daytime drowsiness 60 nocturnal awakenings 60 somnolence dizziness 60 Gaboxadol 60 nighttime awakenings 60 apneic episodes 60 guanfacine extended release 60 Tasimelteon 60 menstrual pain 60 refractory gout 60 GERD symptoms 60 CIPN 60 GH deficiency 60 ACTEMRA TM 60 clomipramine 60 menopausal symptom 59 SRBD 59 dysmenorrhoea 59 hyperprolactinemia 59 migraine prophylaxis 59 SILENOR TM 59 idiopathic Parkinson disease 59 mania hypomania 59 PLMS 59 CPAP adherence 59 narcolepsy obstructive sleep apnea 59 enuresis 59 functional dyspepsia 59 acute mania 59 systemic lupus erythematosus SLE 59 RSD# oral 59 teriflunomide 59 GSK# [002] 59 frequent awakenings 59 reflux symptoms 59 zaleplon 59 venlafaxine XR 59 opioid naive 59 daytime somnolence 59 Hypoactive Sexual Desire Disorder 59 INVEGA ® 59 MIRAPEX ER 59 sleep apnea narcolepsy 59 diarrhea predominant irritable 59 heterozygous FH 58 canakinumab 58 GAMMAGARD 58 syndrome RLS 58 polysomnography PSG 58 growth hormone secretion 58 wakings 58 type 1diabetes 58 baminercept 58 constipation nausea 58 nociceptive pain 58 hyperammonemia 58 R#/MEM # 58 dysmenorrhea 58 pyridostigmine 58 selective modulator 58 PMS symptoms 58 fibromyalgia syndrome 58 airflow limitation 58 hyperalgesia 58 neuropsychiatric symptoms 58 tegaserod 58 allodynia 58 either acutely decompensated 58 circadian rhythm disorders 58 premenstrual symptoms 58 carcinoid syndrome 58 disorder narcolepsy 58 HeFH 58 methylphenidate Ritalin 58 Attention-Deficit/Hyperactivity Disorder ADHD 58 Lixivaptan 58 doxepin 58 QTc prolongation 58 Lu AA# 58 AGILECT R 58 MIRAPEX 58 doxepin HCl 58 ALT flares 58 OSAHS 58 APTIVUS r 58 extrapyramidal symptoms 58 bicifadine 58 narcolepsy sleep apnea 58 gastroesophageal reflux GERD 58 Juvenile Idiopathic Arthritis 58 euthymic patients 58 induce orthostatic hypotension 58 schizophrenia CIAS 58 REYATAZ ritonavir 58 zolpidem Ambien 58 hyperphenylalaninemia HPA due 58 premenstrual syndrome PMS 58 Excessive daytime sleepiness 57 delayed CINV 57 diabetic gastroparesis 57 blinded randomized placebo controlled 57 relapsed MM 57 Ropinirole 57 corrected QT interval 57 timepoints 57 inhaled corticosteroid therapy 57 autoantibody positive 57 nocturnal hypoglycemia 57 dopaminergic therapy 57 dyskinesias 57 subsyndromal 57 anticholinergic effects 57 juvenile idiopathic arthritis 57 sedating antihistamine 57 SSRI citalopram 57 Primary IGFD 57 Chronic insomnia 57 myalgias 57 Nocturia 57 parasomnias 57 daytime sleepiness 57 nocturnal enuresis 57 neuropsychological impairments 57 hypopnea syndrome 57 constipation predominant irritable bowel 57 dextromethorphan DM 57 insomnia sufferers 57 pharmacodynamic profile 57 hour bronchodilation 57 generalized tonic clonic seizures 57 lupus nephritis 57 ziconotide 57 overactive bladder syndrome 57 temporomandibular disorders 57 nalbuphine ER 57 perennial allergic rhinitis 57 insulin detemir 57 corticosteroid therapy 57 Pramipexole 57 opioid induced 57 thorough QT 57 euthymic 57 Plicera 57 fluoxetine Prozac 57 systemic corticosteroid 57 toenail onychomycosis 57 allergic rhinitis hay fever 57 excessive daytime sleepiness 57 generalized seizures 57 receiving XGEVA 57 myoclonus 57 cortisol secretion 57 neurocognitive deficits 57 adrenal suppression 57 intractable hiccups 57 REMINYL ® 57 airway hyperresponsiveness 57 interpersonal psychotherapy 57 acromegalic patients 57 opioid induced bowel dysfunction 57 AGILECT ® 57 Hepatotoxicity 57 sedating antihistamines 57 PD LID 57 painful diabetic neuropathy 57 mixed dyslipidemia 57 tapentadol ER 57 EXJADE 57 CIMZIA ™ 57 SUSTENNA TM 57 T1DM 57 levodopa carbidopa 57 collected saliva samples 57 polysomnogram 57 steroid dexamethasone 56 antimuscarinic 56 headache nasopharyngitis 56 Rotavirus infection 56 efalizumab 56 Ophena TM 56 circadian misalignment 56 corticosteroid dose 56 perimenopausal women 56 Major depressive disorder 56 placebo controlled clinical 56 postoperative ileus 56 EFFEXOR XR 56 decompensated liver disease 56 nucleotide analog 56 bronchial hyperresponsiveness 56 pramlintide 56 hypercholesterolaemia 56 bronchodilatory 56 Psychosocial interventions 56 Tolvaptan 56 FSAD 56 Major Depressive Disorder 56 Sleep disturbances 56 postsurgical pain 56 atopic eczema 56 rheumatic disorders 56 recurrent herpes labialis 56 psychophysiological 56 #mg/day [001] 56 trospium 56 attention-deficit/hyperactivity disorder ADHD 56 safinamide 56 Irritable Bowel Syndrome IBS 56 failure ADHF 56 DPNP 56 gastrointestinal symptoms 56 nocturnal hypoglycaemia 56 oxcarbazepine 56 Symptom severity 56 diabetic peripheral neuropathy DPN 56 mGluR5 NAM 56 idiopathic thrombocytopenic purpura 56 subcutaneous methylnaltrexone 56 rhinoconjunctivitis 56 Parkinson disease PD 56 solifenacin 56 primary hypercholesterolemia 56 nasal allergy symptoms 56 Systemic lupus 56 riociguat 56 left ventricular diastolic 56 unrefreshing sleep 56 inflammatory acne 56 zolmitriptan 56 headache nausea fatigue 56 tardive dyskinesia TD 56 levodopa therapy 56 somatic complaints 56 recurrent abdominal pain 56 Obstructive Sleep Apnea OSA 56 Milnacipran 56 prazosin 56 Wisconsin Sleep Cohort 56 anticholinergic medication 56 tryptophan depletion 56 2A receptor agonist 56 diarrhea dyspepsia 56 HIV HCV coinfected 56 prolonged QT interval 56 Severe Primary IGFD 56 Adalimumab 56 paliperidone 56 myotonia 56 INVEGA ® SUSTENNA ® 56 obstructive sleep 56 oral rivaroxaban 56 Zolpimist ™ 56 Hemophilia B 56 basal cell nevus syndrome 56 primary Restless Legs 56 Traficet EN 56 behavioral disturbances 56 nausea headache dizziness 56 hypomanic episodes 56 QT intervals 56 overt nephropathy 56 post herpetic neuralgia PHN 56 antidepressants fluoxetine 56 MSLT 56 MAP# 56 hyperglycaemia 56 psychostimulants 56 INS# [001] 56 mixed hyperlipidemia 56 somatostatin analog 56 ragweed allergic 55 Iron deficiency anemia 55 miglustat 55 intravenous CK # 55 Cluster headaches 55 chronic neuropathic pain 55 arousals 55 heFH 55 selegiline 55 treprostinil 55 Tasigna prolongs 55 intermittent hypoxia 55 symptomatic neurogenic orthostatic hypotension 55 obstructive apnea 55 clinically meaningful reductions 55 bowel syndrome 55 parkinsonian symptoms 55 HPA axis suppression 55 syndrome OSAS 55 severe hypoglycaemia 55 parkinsonian 55 Androxal TM 55 relapsing multiple sclerosis 55 status epilepticus 55 NUVIGIL 55 OHR/AVR# 55 metastatic uveal melanoma 55 mirtazapine 55 VaD 55 antiretroviral naive 55 NIASPAN 55 receptor inhibitor 55 heavy menstrual bleeding 55 neuroleptics 55 cataplexy 55 gamma secretase inhibitor 55 oxypurinol 55 CIMZIA TM 55 insomnia somnolence 55 moderate ulcerative colitis 55 Rheumatoid Arthritis RA 55 synthetic retinoid 55 pediatric bipolar disorder 55 transaminase elevations 55 placebo controlled clinical trials 55 monoamine oxidase inhibitors 55 hormones ghrelin 55 nasal symptoms 55 akinetic mutism 55 armodafinil 55 flecainide 55 COPD exacerbation 55 RISPERDAL ® 55 somatic symptoms 55 ZOMIG 55 thrombocytopenia neutropenia 55 headache abdominal pain 55 hypoparathyroidism 55 glucocorticoid therapy 55 glycated hemoglobin levels 55 juvenile idiopathic arthritis JIA 55 anovulation 55 torsemide ER 55 clinically meaningful improvement 55 Paliperidone 55 serum bicarbonate 55 platelet dysfunction 55 acute migraine 55 NP2 Enkephalin 55 Cariprazine 55 DEB# 55 insomnia sleep apnea 55 Overactive bladder 55 Safinamide 55 night wakings 55 habitual snoring 55 nasopharyngitis headache 55 diarrhea predominant IBS 55 depressive symptomatology 55 hypovolemia 55 fever headache tiredness 55 serum cortisol 55 Galantamine 55 nausea constipation 55 ALISTA 55 disorder FSAD 55 Oral NKTR 55 tolterodine 55 inhaled budesonide 55 Sexsomnia 55 elevated ALT 55 activate AMPK 55 tarenflurbil 55 dosing frequency 55 GI motility disorders 55 Parkinson disease levodopa induced 55 antiemetics 55 plasma pharmacokinetics 55 ROZEREM 55 major depressive disorder 55 Bruxism 55 allostatic 55 vecuronium 55 lomitapide 55 SILENOR TM doxepin HCl 55 virus HCV infection 55 zileuton 55 dyslipidaemia 55 pharmacodynamic parameters 55 PsA 55 Cataplexy 55 nighttime heartburn 55 CIMZIA TM certolizumab pegol 55 ULTRAM ER 55 pruritis 55 Zoraxel 55 gabapentin enacarbil 55 attain statistical significance 55 acute psychosis 55 Effexor venlafaxine 55 Mirapexin 55 albiglutide 55 torsade de pointes 55 somnolence sleepiness 55 salmeterol fluticasone 55 prucalopride 55 carotid atherosclerosis 55 midazolam Versed 55 hepatic fibrosis 55 acid reflux heartburn 55 infantile spasms 55 Ramelteon 55 orally inhaled migraine 55 Acute Bacterial Sinusitis ABS 55 overt hypothyroidism 55 hypothalamic pituitary adrenal axis 55 Valdoxan 55 anterior uveitis 55 noninfectious uveitis 55 unexplained syncope 55 Circadin 55 immune thrombocytopenic purpura ITP 55 adipiplon 55 nonepileptic seizures 55 antipsychotic efficacy 55 virological response 55 antiandrogens 55 oxycodone CR 55 postpartum mood 55 dirucotide MBP# 55 N#HSWD 55 orally administered synthetic retinoid 55 oral antidiabetes drugs 55 analgesic medications 55 AGHD 55 anti Parkinsonian 55 CTAP# Capsules 55 Obstructive sleep apnea OSA 55 symptom flare ups 55 rituximab Rituxan 55 sleep disorders 55 overnight polysomnography 55 ORENCIA R 55 vomiting constipation 55 Corlux 55 neuroleptic 55 INVEGA ™ 55 haematologic 55 sJIA 55 double blinded placebo 55 non menstrual pelvic 55 allergic rhinitis 55 rheumatoid arthritis psoriatic arthritis 55 TELINTRA 55 narcolepsy cataplexy 55 premenstrual dysphoric disorder 55 LHON 54 IBS symptoms 54 sleep hormone melatonin 54 NPH insulin 54 prolactin elevation 54 AA Amyloidosis 54 hyperuricaemia 54 sedating medications 54 divalproex sodium 54 EDARBI 54 hepatic encephalopathy HE 54 Blinatumomab 54 extrapyramidal disorder 54 potentiation 54 Beta catenin pathway 54 Toviaz 54 hyperactivity impulsivity 54 pramipexole 54 imipramine 54 treat premature ejaculation 54 vertigo dizziness 54 neuropsychiatric disorder 54 CP CPPS 54 moderate renal impairment 54 dose limiting toxicities 54 Circadian rhythm 54 hematological toxicity 54 MMRV vaccine 54 lacosamide 54 leukotriene receptor antagonist 54 Paxil paroxetine 54 NMDA antagonists 54 dose escalation phase 54 gastrointestinal disturbances 54 recurrent miscarriage 54 PDE# inhibitors 54 acute postoperative 54 sertraline Zoloft 54 bradykinesia 54 headache vomiting 54 atypical neuroleptics 54 hypocretin 54 dextofisopam 54 clinically meaningful improvements 54 Migraine headache 54 comorbid anxiety 54 analgesic efficacy 54 risperidone Risperdal 54 ALVESCO HFA 54 TEAEs 54 monoamine 54 overactive bladder OAB 54 zafirlukast 54 Heavy menstrual bleeding 54 zonisamide SR 54 aripiprazole Abilify 54 primidone 54 postherpetic neuralgia 54 Opioid induced 54 mood swings irritability 54 postoperative nausea 54 CONCERTA ® 54 Perforomist Inhalation Solution 54 PNES 54 dysfunctional voiding 54 OAB symptoms 54 episodic migraine 54 Pagoclone 54 miconazole Lauriad ® 54 aripiprazole 54 azoospermia 54 Nuvigil armodafinil 54 VAPRISOL 54 irregular menses 54 Toxicities 54 Magnesium deficiency 54 Fibromyalgia Syndrome FMS 54 Generalized anxiety disorder 54 tenderness clinical mastalgia 54 Syndrome RLS 54 gastro oesophageal reflux 54 Restless Legs Syndrome 54 opioid analgesia 54 SILENOR ™ 54 conventional DMARDs 54 metabolic dysfunction 54 Hypotension 54 intravascular hemolysis 54 ocular allergies 54 single ascending dose 54 polyuria 54 QTc interval 54 proliferative diabetic retinopathy 54 desmopressin 54 nonallergic rhinitis 54 SSRI SNRI 54 hypopneas 54 anthracycline chemotherapy 54 donepezil Aricept 54 gastro esophageal reflux 54 arthralgias 54 TMJD 54 dosing cohort 54 subcutaneous PRO 54 Peripheral edema 54 choroidal vasculopathy 54 bipolar depression 54 conventional antipsychotics 54 RLAI 54 primary axillary hyperhidrosis 54 sleep disturbances 54 urinary incontinence UI 54 primary dysmenorrhea 54 TNF alpha inhibitor 54 peripheral neuropathic pain 54 Wernicke Korsakoff syndrome 54 Withdrawal symptoms 54 ALT elevations 54 PRX # 54 rFIXFc 54 pouchitis 54 impaired cognition 54 RSV infections 54 chronic prostatitis 54 Provigil modafinil 54 severe exacerbations 54 hypocalcemia 54 SHPT 54 avanafil PDE5 inhibitor 54 rotigotine 54 phase IIb trial 54 systemic hypotension 54 CMV infection 54 COPD exacerbations 54 poststroke 54 serotonin norepinephrine reuptake inhibitors 54 Chronic ITP 54 diarrhea headache nausea 54 hyperacidity 54 Chemotherapy induced 54 long acting bronchodilator 54 hypothalamic amenorrhea 54 Generalized Anxiety Disorder 54 O PPDS 54 NMDA antagonist 54 photosensitivity rash 54 LHRH agonists 54 inhaled iloprost 54 nasal obstruction 54 erythropoietic 54 isoproterenol 54 Zolpimist 54 syndrome IBS 54 adrenocorticotropic hormone ACTH 54 antiepileptics 54 ER CHOP 54 Neovascular AMD 54 Serdolect ® 54 treat narcolepsy 54 mood dysregulation 54 apneas 54 psoriatic arthritis PsA 54 BoNTA 54 serum lipid levels 54 pentoxifylline 54 IPL# 54 duloxetine Cymbalta 54 Phase 1a clinical 54 abrupt discontinuation 54 blepharospasm 54 viral kinetics 54 quetiapine Seroquel 54 antithrombotics 54 treatment naive genotype 54 Topiramate 54 active ankylosing spondylitis 54 opioid naïve 54 polymyalgia rheumatica 54 serum urate levels 54 intracranial hypertension 54 headache nausea dizziness 54 neurocognitive impairment 54 confusional arousals 54 female sexual arousal 54 Muscle relaxants 54 stellate ganglion block 54 TMS Therapy 54 spontaneous bowel movements 54 adjunctive placebo 54 neovascular form 54 reflux disease 54 poststroke depression 54 citalopram 54 DFMO 54 tiagabine 54 chronic idiopathic urticaria 54 pulmonary hypertension PH 54 Prodarsan ® 54 myalgia arthralgia 54 habitual snorers 54 C1 INH deficiency 54 MoxDuo TM IR 54 allergic inflammation 54 venlafaxine Effexor 54 Bifeprunox 54 hypercalcemia 54 gastrointestinal motility 54 Fabry Disease 54 Lennox Gastaut Syndrome 54 null responder HCV 54 NATRECOR ® 54 Depressive symptoms 54 rufinamide 54 superficial bladder cancer 54 intravenous cyclophosphamide 54 erosive GERD 54 hepatic encephalopathy 54 serotonin norepinephrine reuptake inhibitor 54 nulliparous women 54 opioid dependent 54 bexarotene 54 ABILIFY Injection 54 tranylcypromine 54 ADHD symptoms 54 KAPVAY ™ 54 prescribed proton pump 54 Phase Ib clinical 54 almorexant 54 depressive symptoms 54 INVEGA ® SUSTENNA TM 53 INVEGA SUSTENNA 53 Trimesta 53 Imipramine 53 infliximab Remicade 53 anti convulsants 53 mucosal inflammation 53 ZOLINZA 53 ziprasidone 53 Premenstrual Dysphoric Disorder 53 paricalcitol 53 antidepressant efficacy 53 Golimumab 53 atopic asthma 53 postoperative ileus POI 53 ralfinamide 53 cerebral ischemia 53 RLS sufferers 53 cough wheezing 53 malarial anemia 53 diarrhea flatulence 53 syndrome gastroesophageal reflux 53 pregabalin 53 olfactory dysfunction 53 proliferative retinopathy 53 BPH symptoms 53 dyskeratosis congenita 53 leptin deficient mice 53 Parnate 53 Febrile neutropenia 53 adrenal function 53 autonomic dysfunction 53 ANCA associated 53 manic episode 53 parkinsonism 53 polycystic ovary syndrome PCOS 53 untreated OSA 53 antidepressive 53 symptomatic BPH 53 prokinetic agent 53 pagoclone 53 Allergic Rhinitis 53 neurosensory 53 leukotriene receptor antagonists 53 hypercalciuria 53 probiotic supplementation 53 Akathisia 53 bupropion XL 53 Systemic Lupus Erythematosus 53 syncope fainting 53 Silenor ® doxepin 53 rheumatoid arthritis RA 53 cardiac repolarization 53 GnRH agonist 53 oxygen desaturation 53 Focalin XR 53 anticholinergics 53 cardiac autonomic 53 Disorder FSAD 53 psychosomatic symptoms 53 upper airway obstruction 53 Rotigotine 53 Premature ejaculation 53 topiramate Topamax 53 oxybutynin 53 Bipolar Mania 53 hypoglycaemic episodes 53 constipation predominant 53 neurogenic orthostatic hypotension 53 norepinephrine reuptake inhibitor 53 Serious adverse reactions 53 evaluating mipomersen 53 6R BH4 53 rheumatic disease 53 sodium thiosulfate STS 53 CRVO 53 chronic rhinosinusitis CRS 53 comorbid ADHD 53 MGd 53 Eszopiclone 53 cutaneous lupus 53 INVEGA R 53 placebo controlled studies 53 vWD 53 oral prednisolone 53 opioid bowel dysfunction 53 depressive episodes 53 anticholinergic 53 Pimavanserin 53 neovascular 53 mild renal insufficiency 53 octreotide LAR 53 irritability headaches 53 Female Sexual Arousal 53 HIV lipodystrophy 53 HBeAg positive 53 nasal allergies 53 DETROL LA 53 Phase IIA 53 Transcranial magnetic stimulation 53 triptan 53 comorbid disorders 53 rhinovirus infection 53 febrile illness 53 reuptake inhibitor 53 hepatorenal syndrome 53 amnestic mild cognitive impairment 53 osteoarthritic pain 53 sleepiness 53 nocturia 53 Cimzia ® certolizumab pegol 53 urinary leakage 53 idiopathic PD 53 asthmatic symptoms 53 ADPKD 53 Rasagiline 53 milrinone 53 vaso occlusive crisis 53 T2DM 53 RSV infection 53 Entereg TM 53 delayed gastric emptying 53 glucocorticoid induced osteoporosis 53 Juvenile Idiopathic Arthritis JIA 53 unexplained abdominal pain 53 weekly intravenous infusions 53 attention-deficit/hyperactivity 53 CYP #A# 53 forodesine 53 daily subcutaneous injections 53 symptomatic VTE 53 Atopic dermatitis 53 SEROQUEL R 53 knee osteoarthritis OA 53 transaminase levels 53 Neuropathic pain 53 serum IGF 53 INVEGA 53 cardiac conduction 53 fluoxetine paroxetine 53 onset sepsis 53 antiseizure drug 53 benign paroxysmal positional vertigo 53 SNT MC# 53 treat chronic sinusitis 53 herpes zoster shingles 53 adrenocorticotropic hormone 53 brivaracetam 53 amoxicillin clavulanate 53 opioid induced constipation 53 prodromal symptoms 53 restorative sleep 53 comorbid depression 53 subcutaneous infusion 53 anxiolytic 53 Triptan 53 affective psychoses 53 highly immunogenic 53 immune thrombocytopenic purpura 53 abdominal pain vomiting diarrhea 53 Bronchiectasis 53 diabetes mellitus DM 53 chronic periodontitis 53 interstitial pneumonia 53 steroid refractory ulcerative 53 Persistent Sleep 53 interferon ribavirin 53 BNC# 53 fatal myelination disorder 53 peritumoral brain edema 53 neurologic disorder 53 elotuzumab 53 profuse diarrhea 53 fructose intolerant 53 CANCIDAS 53 varicella infection 53 chronic idiopathic thrombocytopenic purpura 53 fever diarrhea vomiting 53 apnea hypopnea 53 Sjogren syndrome 53 R#/MEM 53 orthostatic hypotension 53 Enkephalin 53 thrombocytopenic patients 53 chronic plaque psoriasis 53 anhedonia 53 Drowsiness 53 hepatitis C genotype 53 Belimumab 53 ascending doses 53 SGPT 53 quetiapine XR 53 metastatic carcinoid tumors 53 inattention impulsivity 53 Prozac fluoxetine 53 meta regression 53 chronic renal insufficiency 53 recurrent glioma 53 psychopharmacologic 53 venlafaxine ER 53 amisulpride 53 prodrug stimulant 53 Chronic constipation 53 G6PD deficiency 53 maximal doses 53 Ménière disease 53 Teriflunomide 53 isolated systolic hypertension 53 thunderclap headache 53 PGTC seizures 53 Chronic Migraine 53 Proellex TM 53 moderate hepatic impairment 53 recurrent seizures 53 progressive PsA 53 Oral corticosteroids 53 chronic migraine headaches 53 Phenoptin 53 investigational atypical antipsychotic 53 QVA# 53 recurrent glioblastoma multiforme 53 immunomodulatory therapy 53 thyroid hormone deficiency 53 Zileuton 53 Primary endpoints 53 Laquinimod 53 Natalizumab 53 clinical pharmacology studies 53 parasitemia 53 Denufosol 53 prolactin levels 53 adrenal insufficiency 53 bardoxolone methyl 53 Eltrombopag 53 congenital hypothyroidism 53 QTc intervals 53 Vaprisol 53 SGS# 53 penile erection 53 KETEK 53 gastrointestinal dysfunction 53 Lennox Gastaut syndrome 53 immunocompetent adults 53 PULMICORT RESPULES 53 chronic myeloid 53 chronic idiopathic constipation 53 atopic disorders 53 INCB# [003] 53 Proquin XR 53 claudication 53 Sleep disordered breathing 53 Xyzal ® 53 desipramine 53 antibiotic minocycline 53 Vimpat R 53 monozygotic twin 53 neurodevelopmental outcome 53 hypoglycemic episodes 53 HGS# 53 circadian cytokine modulator 53 primary dysmenorrhoea 53 adalimumab Humira 53 Etanercept 53 apneic 53 confusion disorientation 53 extrapyramidal symptoms EPS 53 runny nose headache 53 refractory epilepsy 53 neuro psychiatric disorders 53 alpha interferons 53 phenothiazines 53 PLX STROKE targeting 53 Dysmenorrhea 53 alexithymia 53 secondary efficacy endpoints 53 Dasatinib 53 ALGRX 53 premenopause 53 serum phosphate 53 Fluid retention 53 Sociodemographic 53 Daytime sleepiness 53 postoperative AF 53 allergen immunotherapy 52 OMNARIS HFA 52 primary IGFD 52 Zaleplon 52 prodrome 52 anticonvulsant 52 phase IIa 52 Sanofi Pasteur Fluzone 52 hemorrhagic cystitis